Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...
Therefore, it is critical to identify novel actionable alterations in SDH-deficient GIST. Seventeen tumor samples from 14 patients with SDH-deficient GIST underwent NGS. Mutational load was low, ...
Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results